通过基编辑在小鼠中纠正致病性线粒体DNA突变
Jose D Barrera-Paez1, Sandra R Bacman2, Till Balla3
1Graduate Program in Human Genetics, University of Miami Miller School of Medicine, 1501 NW 10th Avenue (M-860), Miami, FL 33136, USA.
Science translational medicine
|January 29, 2025
概括
使用DddA衍生的细胞因子基编辑器 (DdCBE) 的线粒体基因治疗成功地恢复了小鼠的线粒体转移RNA (tRNA) 氨酸水平. 然而,仔细的剂量监测至关重要,以防止非目标线粒体DNA编辑和不良影响.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 主要线粒体疾病通常源于线粒体DNA (mtDNA) 的突变.
- 线粒体转移RNA阿拉宁 (mt-tRNAAla) 基因中的特定突变 (m.5024C→T) 破坏了它的结构,导致了功能障碍.
研究的目的:
- 评估DddA衍生型细胞因子基编辑器 (DdCBE) 对纠正病态mtDNA突变的疗效.
- 通过在小鼠模型中恢复mt-tRNAAla功能来评估DdCBE作为线粒体疾病的基因疗法的潜力.
主要方法:
- 一个DdCBE结构被设计为在mt-tRNAAla基因中引入补偿编辑 (m.5081G→A).
- 该DdCBE在试验室中在突变细胞系中进行了测试,并在小鼠体内通过腺相关病毒9 (AAV9) 进行了体内输送.
- 在治疗后分析了线粒体tRNA水平,乳酸度和非目标编辑.
主要成果:
- 在体外编辑在突变细胞中增加了高达78%的mt-tRNAAla水平.
- 在体内,DdCBE以剂量依赖的方式恢复了心脏和骨肌肉中的mt-tRNAAla数量,降低了乳酸水平的升高.
- 高剂量的AAV9-DdCBE由于大量的非目标mtDNA编辑导致了严重的不良反应.
结论:
- 通过纠正特定的mtDNA突变,DdCBE显示出作为治疗线粒体疾病的基因疗法工具的前景.
- 仔细优化DdCBE的剂量至关重要,以平衡治疗效益并减轻非目标编辑和毒性的风险.
相关概念视频
Animal Mitochondrial Genetics
7.4K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K
In-vitro Mutagenesis
13.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.7K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
CRISPR
49.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.2K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K


